Circulating Angiostatin, bFGF, and Tie2/TEK Levels and Their Prognostic Impact in Bladder Cancer
Urology, 05/21/2012
Clinical Article
Szarvas T et al. – The characteristic differences in the circulating levels of angiostatin, tyrosine endothelial kinase (TEK), and basic fibroblast growth factor between patients and controls, suggest the presence of a tumor–induced proangiogenic milieu in bladder cancer. Serum TEK levels may contribute to a more reliable preoperative risk stratification in muscle–invasive bladder cancer and therefore may help to optimize therapeutic decisions.
